While some people have linear careers, there are those whose careers develop through a path dictated by a certain sense of calling. In the case of Dr Priyadarshini Roy, her journey for more than three decades has seen her navigate change purposefully, build high-performing teams, develop scientific strategies, and become an internationally acclaimed author as well.
She doesn’t belong in one box. She’s a physician, clinical researcher, team building expert in publishing and poetry, and all these identities weren’t acquired by accident but through a purposeful and brave choice.
Her story started from the wards of eastern India when she worked as a physician after obtaining her MBBS and MD degrees. She was working in various state government or private sector hospitals, like the S.A.I.L Hospital in Rourkela, before joining private sector health care providers like Kothari and AMRI Hospitals of Kolkata.
“I nurtured the aspiration to explore a new field in medicine,” she says. That aspiration drew her towards clinical research, a domain that was, at the turn of the millennium, still finding its footing in India.
A Leap into the Unknown
In 2003, Dr Roy made a pivotal decision. She relocated to Hyderabad and joined Nizam’s Institute of Medical Sciences, where she worked under the mentorship of Dr M.U.R. Naidu. Here, she designed and conducted clinical trials across all phases of study, with Phase I trials proving especially demanding and intellectually invigorating.
Here, she absorbed exposure across therapeutic areas and collaborated with a diverse range of sponsors. Then, within a few years, she made another leap: from academia into the pharmaceutical industry.
“Unlike clinical practice, there was no defined roadmap. I had to carve my own path while staying grounded in my values and principles,” she says.
That transition opened a world she had only glimpsed from the outside. Working with professionals across disciplines, statisticians, regulatory specialists and scientists, she discovered that pharmaceutical drug development is as much about people as it is about data.
Building Something from Nothing
If one accomplishment defines Dr Roy’s corporate years, it is this: she led the establishment of an in-house medical-scientific writing team in India for a global pharmaceutical organization an initiative undertaken for the first time within that company.
She recruited talent from backgrounds as varied as medicine, dentistry, pharmacy, chemistry, microbiology, and graphic design. Many came with no prior exposure to clinical research. Most were strong individual contributors. Her task was to shape them into a cohesive, high-performing unit capable of delivering consistent, time-bound, world-class output.
She built workflows. She implemented scientific publication tools. She established a centralized talent pool that eventually supported global operations, reduced external dependencies, and raised the efficiency bar for the entire organisation. That business unit became a benchmark internally, and the people she mentored have since gone on to lead careers in top pharmaceutical organisations across the world.
Navigating Adversity with Resolve
No career of this scope unfolds without friction. Dr Roy speaks candidly of periods marked by bias and difficult interpersonal dynamics challenges that are, as she acknowledges, hard to articulate and even harder to navigate. “What helped me during such times was resilience, the courage to stay steadfast, and a strong determination to prove my capabilities,” she reflects.
She does not dwell on these experiences as wounds. She regards them as formative trials that deepened her resolve, sharpened her judgment, and ultimately contributed to the leader she became.
Leadership With a Conscience
Ask Dr Roy about her leadership philosophy, and she reaches quickly for accountability rather than authority. Leadership in pharmaceutical drug development, she believes, is defined not by position, but by responsibility, particularly at the intersection of science and human impact.
Every protocol she has worked on, every risk she has assessed, has had real patients on the other side of the equation. That awareness shapes everything she does. She leads with integrity, communicates with clarity, and adapts her approach to the phase of development and the needs of her team.
She believes that a leader’s first responsibility is understanding the individuals they lead. Encouraging curiosity, normalizing the act of asking questions, seeking help, and fostering genuine collaboration are, in her view, the building blocks of a well-rounded team.
“The teams evolved into high-performing units and many individuals from these teams have since excelled and built strong careers within and in leading pharmaceutical organizations globally,” she notes
This approach has consistently produced professionals who are not only technically capable but also adaptable, curious, and confident in the face of ambiguity.
A Legacy in Progress
The awards she has received, among them, are the Maharashtra Excellence Awards 2026, the Bharat Gaurav Ratna Sanman 2025, and an Honorary D.Litt. gesture at the breadth of her impact. But Dr Roy measures success differently.
The most meaningful recognition, she says, comes from the people she has worked with and the lives she has touched, not from certificates or titles, but from lasting goodwill.
“Identify your strengths and choose a path that aligns with your aspirations. Failures and setbacks are part of the journey; resilience lies in rising again. Stay agile in both mind and spirit, and remember that your effort is ultimately an investment in your own growth,” she advises
She continues to work as an independent consultant to the pharmaceutical industry, healthcare, and academia, carrying forward the same values she has held throughout: integrity, collaboration, precision, compassion, and an undiminished curiosity about what comes next.